Mercado de diagnóstico de cáncer de mama: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00003015
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Breast Cancer Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

El cáncer de mama es el crecimiento incontrolable de células tumorales en las mamas. Generalmente, el cáncer se forma en los lóbulos o en los conductos de la mama. Hay dos tipos de cáncer de mama, el cáncer de mama invasivo y el cáncer de mama no invasivo. Durante los últimos años se ha producido un aumento de los casos de cáncer de mama en mujeres. Recientemente, el cáncer de mama también se está detectando en hombres. La Sociedad Estadounidense del Cáncer estimó que en 2015, más de 2000 hombres serían diagnosticados y más de 400 morirían a causa de la enfermedad. Se espera que la creciente prevalencia del cáncer de mama junto con la tecnología avanzada para su diagnóstico impulsen el crecimiento del mercado de diagnóstico del cáncer de mama durante el período de pronóstico. Además, se prevé que la introducción de nuevos y mejores productos por parte de los fabricantes ofrezca oportunidades de crecimiento a las empresas del mercado. El "Análisis del mercado global de diagnóstico de cáncer de mama hasta 2031" es un estudio especializado y en profundidad de la industria de TI para la atención médica con un enfoque en la tendencia del mercado global. El informe tiene como objetivo proporcionar una visión general del mercado global con una segmentación detallada del mercado por tipo de detección, tecnología y geografía. Se espera que el mercado global sea testigo de un alto crecimiento durante el período previsto. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores del mercado de diagnóstico de cáncer de mama y ofrece tendencias y oportunidades clave en el mercado. El mercado mundial de diagnóstico del cáncer de mama está segmentado según el tipo y la tecnología de detección. Según el tipo de detección, el mercado se segmenta en pruebas de laboratorio, biopsia, imágenes y otros tipos de detección. Según la tecnología, el mercado de diagnóstico del cáncer de mama se clasifica en hibridación fluorescente in situ (FISH), hibridación genómica comparativa (CGH), inmunohistoquímica (IHC) y otras tecnologías. El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y un pronóstico del mercado mundial de diagnóstico de cáncer de mama según el tipo y la tecnología de detección. También proporciona el tamaño del mercado y el pronóstico hasta 2031 para el mercado general con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur y Central. El mercado de diagnóstico de cáncer de mama de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y el pronóstico de 13 países a nivel mundial junto con las tendencias actuales y las oportunidades que prevalecen en la región. Se espera que América del Norte contribuya con la mayor participación en el mercado de diagnóstico de cáncer de mama en los próximos años, debido a la creciente prevalencia de casos de cáncer de mama en la región durante los últimos años. Se espera que Asia Pacífico sea testigo de un crecimiento significativo en el mercado durante el período previsto, debido al aumento de la inversión de actores extranjeros en economías en desarrollo como China e India. El informe analiza los factores que afectan el mercado de diagnóstico de cáncer de mama tanto desde el lado de la demanda como de la oferta y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, los impulsores, las restricciones, las oportunidades y las tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber; América del Norte, Europa, APAC, MEA y América del Sur y Central después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de diagnóstico de cáncer de mama en estas regiones. El informe también incluye los perfiles de empresas clave en el diagnóstico del cáncer de mama junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos 3 años y desarrollos clave en los últimos cinco años. Algunos de los actores clave que operan en el mercado de diagnóstico del cáncer de mama incluyen Abbott, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GENERAL ELECTRIC COMPANY, Hologic, Inc., Koninklijke Philips NV, Micrima Limited, Provista Diagnostics, Inc., Siemens Healthcare GmbH y Thermo Fisher Scientific Inc., entre otros.

Breast Cancer Diagnostics Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo de detección
  • pruebas de laboratorio
  • biopsia
  • imágenes y otros tipos de detección
By Tecnología
  • hibridación fluorescente in situ
By Geografía
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
Regions and Countries Covered América del Norte
  • EE. UU.
  • Canadá
  • México
Europa
  • Reino Unido
  • Alemania
  • Francia
  • Rusia
  • Italia
  • resto de Europa
Asia-Pacífico
  • China
  • India
  • Japón
  • Australia
  • resto de Asia-Pacífico
América del Sur y Central
  • Brasil
  • Argentina
  • Resto de América del Sur y Central
Medio Oriente y África
  • Sudáfrica
  • Arabia Saudita
  • Emiratos Árabes Unidos
  • Resto de Medio Oriente y África
Market leaders and key company profiles
  • Abbott
  • F Hoffmann La Roche Ltd
  • Fujifilm Holdings Corporation
  • GENERAL ELECTRIC COMPANY
  • Hologic Inc
  • Koninklijke Philips N V
  • Micrima Limited
  • Provista Diagnostics Inc
  • Siemens Healthcare GmbH
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Abbott
    2. F. Hoffmann-La Roche Ltd
    3. Fujifilm Holdings Corporation
    4. GENERAL ELECTRIC COMPANY
    5. Hologic, Inc.
    6. Koninklijke Philips N.V.
    7. Micrima Limited
    8. Provista Diagnostics, Inc.
    9. Siemens Healthcare GmbH
    10. Thermo Fisher Scientific Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Medical Device : READ MORE..